File(s) under permanent embargo

Future of PD-1/PD-L1 axis modulation for the treatment of triple-negative breast cancer

journal contribution

posted on 2022-01-01, 00:00 authored by Maryam NakhjavaniMaryam Nakhjavani, Sarah ShigdarSarah Shigdar

Future of PD-1/PD-L1 axis modulation for the treatment of triple-negative breast cancer

History

Journal

Pharmacological Research

Volume

175

Article number

106019

Pagination

1 - 11

Publisher

Elsevier

Location

Amsterdam, The Netherlands

Publisher DOI

https://doi.org/10.1016/j.phrs.2021.106019

ISSN

1043-6618

eISSN

1096-1186

Language

eng

Author URL

https://www.ncbi.nlm.nih.gov/pubmed/34861397

Publication classification

C1 Refereed article in a scholarly journal

Usage metrics

Categories

No categories selected

Keywords

Aptamer Immunotherapy Monoclonal antibody PD-1 PD-L1 Triple-negative breast cancer Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy CELL DETECTION DNA APTAMER MECHANISMS SELECTION LIGANDS BINDING NEOADJUVANT TORIPALIMAB

Licence

All Rights Reserved

Exports